DaVita Inventory 2010-2024 | DVA

DaVita inventory from 2010 to 2024. Inventory can be defined as the total value of inventories in all stages of completion.
  • DaVita inventory for the quarter ending September 30, 2024 was $0.129B, a 17.68% increase year-over-year.
  • DaVita inventory for 2023 was $0.143B, a 31.14% increase from 2022.
  • DaVita inventory for 2022 was $0.109B, a 1.58% increase from 2021.
  • DaVita inventory for 2021 was $0.107B, a 3.76% decline from 2020.
DaVita Annual Inventory
(Millions of US $)
2023 $143
2022 $109
2021 $107
2020 $112
2019 $98
2018 $107
2017 $182
2016 $160
2015 $186
2014 $136
2013 $89
2012 $78
2011 $76
2010 $76
2009 $70
DaVita Quarterly Inventory
(Millions of US $)
2024-09-30 $129
2024-06-30 $127
2024-03-31 $146
2023-12-31 $143
2023-09-30 $110
2023-06-30 $110
2023-03-31 $107
2022-12-31 $109
2022-09-30 $107
2022-06-30 $110
2022-03-31 $108
2021-12-31 $107
2021-09-30 $114
2021-06-30 $115
2021-03-31 $116
2020-12-31 $112
2020-09-30 $106
2020-06-30 $98
2020-03-31 $96
2019-12-31 $98
2019-09-30 $99
2019-06-30 $97
2019-03-31 $104
2018-12-31 $107
2018-09-30 $91
2018-06-30 $113
2018-03-31 $126
2017-12-31 $182
2017-09-30 $154
2017-06-30 $199
2017-03-31 $174
2016-12-31 $160
2016-09-30 $201
2016-06-30 $197
2016-03-31 $193
2015-12-31 $186
2015-09-30 $173
2015-06-30 $159
2015-03-31 $146
2014-12-31 $136
2014-09-30 $115
2014-06-30 $100
2014-03-31 $101
2013-12-31 $89
2013-09-30 $85
2013-06-30 $78
2013-03-31 $77
2012-12-31 $78
2012-09-30 $78
2012-06-30 $78
2012-03-31 $72
2011-12-31 $76
2011-09-30 $73
2011-06-30 $69
2011-03-31 $70
2010-12-31 $76
2010-09-30 $69
2010-06-30 $69
2010-03-31 $68
2009-12-31 $70
2009-09-30 $69
2009-06-30 $65
2009-03-31 $71
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.872B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
Quest Diagnostics (DGX) United States $17.988B 18.23
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00